We are live on ! Find out more
TRAW icon

Traws Pharma
TRAW

29 hedge funds and large institutions have $5.87M invested in Traws Pharma in 2020 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

232% more capital invested

Capital invested by funds: $1.77M → $5.87M (+$4.11M)

225% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 4

67% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 3

38% more funds holding

Funds holding: 21 → 29 (+8)

0.01% more ownership

Funds ownership: 0.01% → 0.02% (+0.01%)

Holders
29
Holders Change
+8
Holders Change %
+38.1%
% of All Funds
0.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
5
Reduced
3
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$1.55M
2
Renaissance Technologies
Renaissance Technologies
New York
+$484K
3
BPA
Beacon Pointe Advisors
California
+$97K
4
SAMH
Shanda Asset Management Holdings
British Virgin Islands
+$78.2K
5
Northern Trust
Northern Trust
Illinois
+$52.3K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$441K
2
Citadel Advisors
Citadel Advisors
Florida
-$55K
3
Victory Capital Management
Victory Capital Management
Texas
-$7.95K
4
TSS
Two Sigma Securities
New York
-$7K
5
CBFP
Cedar Brook Financial Partners
Ohio
-$6K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$3.45M +$1.55M +10,130 +165%
Renaissance Technologies
2
Renaissance Technologies
New York
$672K +$484K +3,166 New
BlackRock
3
BlackRock
New York
$495K +$6.57K +43 +2%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$298K +$23.5K +154 +12%
HWA
5
Hillcrest Wealth Advisors
New Jersey
$142K – – –
BPA
6
Beacon Pointe Advisors
California
$131K +$97K +635 New
Northern Trust
7
Northern Trust
Illinois
$110K +$52.3K +342 +195%
SAMH
8
Shanda Asset Management Holdings
British Virgin Islands
$109K +$78.2K +512 New
QP
9
Quilter Plc
United Kingdom
$89K – – –
UBS Group
10
UBS Group
Switzerland
$71K +$3.67K +24 +8%
CAPTRUST Financial Advisors
11
CAPTRUST Financial Advisors
North Carolina
$59K +$40.8K +267 New
Barclays
12
Barclays
United Kingdom
$57K +$40.8K +267 New
FIA
13
FNY Investment Advisers
New York
$56K +$40.8K +267 New
Jane Street
14
Jane Street
New York
$28K +$20.3K +133 New
Susquehanna International Group
15
Susquehanna International Group
Pennsylvania
$16K -$441K -2,889 -97%
Victory Capital Management
16
Victory Capital Management
Texas
$16K -$7.95K -52 -41%
EWA
17
Exencial Wealth Advisors
Oklahoma
$13K -$1.22K -8 -11%
Rockefeller Capital Management
18
Rockefeller Capital Management
New York
$11K – – –
Commonwealth Equity Services
19
Commonwealth Equity Services
Massachusetts
$10K +$7.33K +48 New
9WM
20
9258 Wealth Management
Ohio
$9K – – –
HF
21
HRT Financial
New York
$9K +$7.03K +46 New
Cerity Partners
22
Cerity Partners
New York
$8K +$6.11K +40 New
Squarepoint
23
Squarepoint
New York
$6K +$4.28K +28 New
LFG
24
Larson Financial Group
Missouri
$1K +$458 +3 New
CAN
25
Cetera Advisor Networks
California
$1K +$764 +5 New
1
2

TRAW Hedge Fund Activity: Q2 2020 in Review

29 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Traws Pharma (TRAW) for Q2 2020, worth a combined $5.87M — up 232% from $1.77M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new TRAW positions and 4 closed out — a net gain of 9 holders — while 5 added to existing stakes and 3 trimmed.

The largest buyer was Vanguard Group, adding an estimated $1.55M. The largest seller was Susquehanna International Group, cutting an estimated $441K.

  • 29 institutional investors held Traws Pharma (TRAW) as of Q2 2020, up from 21 in Q1 2020.
  • Funds reported $5.87M of Traws Pharma stock for Q2 2020, up 232% quarter-over-quarter.
  • 13 funds opened new Traws Pharma positions in Q2 2020 and 4 closed out, a net change of +9 holders.
  • The largest Traws Pharma buyer in Q2 2020 was Vanguard Group, an estimated $1.55M added.
  • The largest Traws Pharma seller in Q2 2020 was Susquehanna International Group, an estimated $441K sold.

Based on aggregated 13F filings for Q2 2020.